This trial shows that TASOX can be safely and effectively given after a short course of radiation, allowing for successful R0 surgery and local control in patients with stage II/III rectal cancer.
- Colorectal Cancer
1 Primary · 1 Secondary · Reporting Duration: Through study completion, an average of 6 months
Side Effects for
1 Treatment Group
TAS102 plus Oxaliplatin
1 of 1
27 Total Participants · 1 Treatment Group
Primary Treatment: Oxaliplatin · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 22 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has the FDA sanctioned Oxaliplatin for public use?
"Oxaliplatin was determined to be a 2 on the safety scale because this is a Phase 2 trial, indicating that there are some records of its safety but no verifiable evidence for efficacy." - Anonymous Online Contributor
Has Oxaliplatin been investigated for any other medical applications?
"Currently, 339 clinical trials are investigating the use of Oxaliplatin with 122 in Phase 3. While many studies for this medication take place in Melbourne, Victoria there is a total of 13673 trial locations around the globe." - Anonymous Online Contributor
What is the aggregate sum of participants involved in this experiment?
"To move forward with this trial, 27 qualified patients will need to be enrolled. These individuals may come from Virginia Mason Medical Center in Orange, California or the University of California Irvine in Portland Oregon." - Anonymous Online Contributor
Are there still vacancies for volunteers in this clinical trial?
"Affirmative. Clinicaltrials.gov states that this medical trial, which was initially posted on July 5th 2022 and amended most recently on the 8th of July, is actively seeking participants. The study requires 27 patients to be recruited from 5 different research locations." - Anonymous Online Contributor
How extensively is this clinical investigation being conducted in the city?
"At present, this research is being conducted at 5 medical centres. These locations include Orange, Portland and New York in addition to two other cities. To minimize travel burdens, it would be best for prospective participants to select the closest trial site available." - Anonymous Online Contributor